A bill to increase reporting transparency and accountability with respect to Food and Drug Administration user fees.

FDA Reporting Transparency and Accountability Act This bill expands reporting requirements related to the performance of the Food and Drug Administration (FDA), including to require additional information on timeliness and personnel and publication every 30 days of information regarding FDA guidance and meetings.